A Basket Trial of Vunakizumab in Inflammatory Skin Diseases

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jan 21, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "A Basket Trial of Vunakizumab in Inflammatory Skin Diseases," is studying the effects of a medication called vunakizumab on patients with inflammatory skin diseases, including psoriasis. The goal is to gather information about how well this treatment works in real-life settings. The study will involve around 10,000 patients who are already receiving vunakizumab, ensuring that their regular medical care will not change simply because they are part of the trial.

To be eligible for this study, participants need to be at least 18 years old and have a diagnosed inflammatory skin condition. They also need to be currently using or planning to use vunakizumab as part of their treatment. If someone decides to join the trial, they will be asked to sign a consent form, and their progress will be monitored for one year. This study is not yet recruiting participants, but it aims to provide valuable insights into the effectiveness of vunakizumab in treating skin diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged ≥ years；
• • had adiagnosis of inflammatory skin disease；
• • Is receiving or plans to receive vunakizumab for treatment;
• • Patients provided written informed consent form.
• Exclusion Criteria:
• • no.